Wolverine Asset Management, LLC and affiliated reporting persons filed Amendment No. 2 to their beneficial ownership statement with respect to Black Hawk Acquisition Corp. (NASDAQ:BKHA) on November 5, 2026, disclosing a 0.00% ownership position in the issuer's ordinary shares as of October 13, 2026.
T. Rowe Price filed a free writing prospectus on November 5, 2026, consisting of a transcript from a VettaFi webinar held November 2, 2026, in which T. Rowe Price's head of digital asset strategy discussed the T. Rowe Price Active Crypto ETF (NYSE:TKNZ) and …
Hudson Pacific Properties, Inc. filed a Form 8-K with the SEC on November 5, 2026, reporting the availability of its financial results and supplemental operating data for the third quarter ended September 30, 2026.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 5, 2026, disclosing terms for Market Linked Securities auto-callable with contingent coupon linked to the Class A common stock of Coinbase Global, Inc., due November 16, 2029.
DT filed an 8-K announcement on November 5, 2026, disclosing the appointment of Daniel Lentz as Chief Financial Officer, effective November 30, 2026, with Josh Kinsell continuing as Chief Accounting Officer.
HCW Biologics Inc. filed a current report on November 5, 2026, disclosing that it entered into a Notes Purchase Agreement with Streeterville Capital, LLC on November 3, 2026, providing for two secured promissory notes totaling $10.2 million in original principal.
Immunic, Inc. filed a Form 8-K with the SEC on November 5, 2026, disclosing that the company hosted a Progressive Multiple Sclerosis Research and Development Day webinar and attaching the accompanying presentation as an exhibit.
Kartoon Studios, Inc. filed a current report on Form 8-K on November 5, 2026, disclosing that its subsidiary-sponsored special purpose acquisition company, Kartoon Studios Acquisition Corp., had submitted a Form S-1 registration statement with the U.S. Securities and Exchange Commission in connection with a …
Myriad Genetics, Inc. filed a Form 8-K on November 5, 2026, disclosing that it detected unauthorized access within its information technology network environment on November 2, 2026.
MetaVia Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing positive interim clinical trial data and an updated corporate presentation.